Craft

B.R.A.I.N. Biotechnology Research and Information Network

Stock Price

€2.2

2024-10-29

Market Capitalization

€54.1 M

2024-10-29

Revenue

€55.3 M

FY, 2023

B.R.A.I.N. Biotechnology Research and Information Network Summary

Company Summary

Overview
B.R.A.I.N. Biotechnology Research and Information Network develops enzymes, biocatalysts, and bioactive natural substances for manufacturers in the chemical and consumer goods industries. The Company identifies and develops bioactive natural compounds, including sugar substitutes and taste modulators, and natural-resource substances for product development in the food manufacturing and animal feed industry, cosmetics, and chemical industries; new or optimized enzymes, and biocatalysts that meet complex process and application requirements; and microorganisms as the functional biomass for optimized industrial production processes or to establish bioprocesses in chemical procedures.
Type
Public
Status
Active
Founded
1993
HQ
Zwingenberg, DE | view all locations
Website
https://www.brain-biotech.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Adriaan Moelker

    Adriaan Moelker, CEO

    • Ute Dechert

      Ute Dechert, VP, Human Resources and Processes

    • Guido Meurer

      Guido Meurer, VP Producer Strain Development

      • Anna C. Eichhorn, Vice Chairwoman of the Supervisory Board

        LocationsView all

        1 location detected

        • Zwingenberg, HE HQ

          Germany

          Darmstädter Str. 34

        B.R.A.I.N. Biotechnology Research and Information Network Financials

        Summary Financials

        Revenue (Q3, 2024)
        €13.2M
        Gross profit (Q3, 2024)
        €7.5M
        Net income (Q3, 2024)
        (€2.6M)
        EBIT (Q3, 2024)
        (€2.3M)
        Enterprise value
        $54.1M

        Footer menu